skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight

Abstract

Over recent years, within the community of radiopharmaceutical sciences, there has been an increased incidence of incorrect usage of established scientific terms and conventions, and even the emergence of ‘self-invented’ terms. Here, in order to address these concerns, an international Working Group on ‘Nomenclature in Radiopharmaceutical Chemistry and related areas’ was established in 2015 to achieve clarification of terms and to generate consensus on the utilisation of a standardised nomenclature pertinent to the field. Upon open consultation, the following consensus guidelines were agreed, which aim to: Provide a reference source for nomenclature good practice in the radiopharma-ceutical sciences; Clarify the use of terms and rules concerning exclusively radiopharmaceutical terminology, i.e. nuclear- and radiochemical terms, symbols and expressions; Address gaps and inconsistencies in existing radiochemistry nomenclature rules; Provide source literature for further harmonisation beyond our immediate peer group (publishers, editors, IUPAC, pharmacopoeias, etc.).

Authors:
 [1]; ORCiD logo [2];  [3];  [4];  [5];  [6];  [7];  [8];  [9];  [10];  [11]
  1. Forschungszentrum Julich (Germany)
  2. King's College London (United Kingdom)
  3. TRIUMF, Vancouver, BC (Canada)
  4. Uppsala Univ. (Sweden)
  5. Brookhaven National Lab. (BNL), Upton, NY (United States)
  6. Keio Univ., Tokyo (Japan)
  7. Seoul National Univ., Seoul (South Korea)
  8. Univ. of Pennsylvania, Philadelphia, PA (United States)
  9. Ludwig Boltzmann Inst. Applied Diagnostics, Vienna (Austria)
  10. National Inst. of Mental Health, Bethesda, MD (United States)
  11. VU Univ. Medical Centre, Amsterdam (The Netherlands)
Publication Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Nuclear Physics (NP) (SC-26)
OSTI Identifier:
1413925
Report Number(s):
BNL-114441-2017-JA
Journal ID: ISSN 0969-8051; R&D Project: KBCH139; KB0202011; TRN: US1800586
Grant/Contract Number:
SC0012704
Resource Type:
Journal Article: Accepted Manuscript
Journal Name:
Nuclear Medicine and Biology
Additional Journal Information:
Journal Volume: 55; Journal Issue: C; Journal ID: ISSN 0969-8051
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY; nomenclature; terminology; consensus guidelines; radiopharmaceutical sciences; nuclear chemistry; radiochemistry

Citation Formats

Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., and Windhorst, Albert D.. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight. United States: N. p., 2017. Web. doi:10.1016/j.nucmedbio.2017.09.004.
Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., & Windhorst, Albert D.. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight. United States. doi:10.1016/j.nucmedbio.2017.09.004.
Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., and Windhorst, Albert D.. Sat . "Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight". United States. doi:10.1016/j.nucmedbio.2017.09.004.
@article{osti_1413925,
title = {Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight},
author = {Coenen, Heinz H. and Gee, Antony D. and Adam, Michael and Antoni, Gunnar and Cutler, Cathy S. and Fujibayashi, Yasuhisa and Jeong, Jae Min and Mach, Robert H. and Mindt, Thomas L. and Pike, Victor W. and Windhorst, Albert D.},
abstractNote = {Over recent years, within the community of radiopharmaceutical sciences, there has been an increased incidence of incorrect usage of established scientific terms and conventions, and even the emergence of ‘self-invented’ terms. Here, in order to address these concerns, an international Working Group on ‘Nomenclature in Radiopharmaceutical Chemistry and related areas’ was established in 2015 to achieve clarification of terms and to generate consensus on the utilisation of a standardised nomenclature pertinent to the field. Upon open consultation, the following consensus guidelines were agreed, which aim to: Provide a reference source for nomenclature good practice in the radiopharma-ceutical sciences; Clarify the use of terms and rules concerning exclusively radiopharmaceutical terminology, i.e. nuclear- and radiochemical terms, symbols and expressions; Address gaps and inconsistencies in existing radiochemistry nomenclature rules; Provide source literature for further harmonisation beyond our immediate peer group (publishers, editors, IUPAC, pharmacopoeias, etc.).},
doi = {10.1016/j.nucmedbio.2017.09.004},
journal = {Nuclear Medicine and Biology},
number = C,
volume = 55,
place = {United States},
year = {Sat Oct 21 00:00:00 EDT 2017},
month = {Sat Oct 21 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on October 21, 2018
Publisher's Version of Record

Citation Metrics:
Cited by: 3 works
Citation information provided by
Web of Science

Save / Share: